These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11313162)

  • 1. Noradrenergic dysfunction and antidepressant treatment response.
    Corrêa H; Duval F; Claude MM; Bailey P; Tremeau F; Diep TS; Crocq MA; Castro JO; Macher JP
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):163-8. PubMed ID: 11313162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
    Rao ML; Ruhrmann S; Retey B; Liappis N; Fuger J; Kraemer M; Kasper S; Möller HJ
    Pharmacopsychiatry; 1996 Sep; 29(5):180-6. PubMed ID: 8895943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.
    Vezmar S; Miljkovic B; Vucicevic K; Timotijevic I; Prostran M; Todorovic Z; Pokrajac M
    J Pharmacol Sci; 2009 May; 110(1):98-104. PubMed ID: 19444001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.
    Demyttenaere K; Van Ganse E; Gregoire J; Gaens E; Mesters P
    Int Clin Psychopharmacol; 1998 Jan; 13(1):11-7. PubMed ID: 9988362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
    Versiani M; Ontiveros A; Mazzotti G; Ospina J; Dávila J; Mata S; Pacheco A; Plewes J; Tamura R; Palacios M
    Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Neuropsychobiology; 1995; 32(1):19-22. PubMed ID: 7566518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amitriptyline metabolism in elderly depressed patients and normal controls in relation to hypothalamic-pituitary-adrenal system function.
    Schmider J; Deuschle M; Schweiger U; Körner A; Gotthardt U; Heuser IJ
    J Clin Psychopharmacol; 1995 Aug; 15(4):250-8. PubMed ID: 7593707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
    Maes M; Van Gastel A; Delmeire L; Meltzer HY
    Biol Psychiatry; 1999 Feb; 45(3):278-84. PubMed ID: 10023502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment.
    Kwon JS; Youn T; Jung HY
    J Affect Disord; 1996 Oct; 40(3):169-73. PubMed ID: 8897116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
    Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C; Ceccherininelli A; Rossi A; Maggini C
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.